Atlas FDA

DIGENE HC2 HIGH RISK HPV DNA TEST AND DIGENE HC2 HPV DNA TEST

FDA premarket approval P890064/S029 · decided 2014-04-14

Approval details

PMA number
P890064
Supplement
S029
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
DIGENE HC2 HIGH RISK HPV DNA TEST AND DIGENE HC2 HPV DNA TEST
Generic name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Applicant
Qiagen Gaithersburg, Inc.
Date received
2013-08-15
Decision date
2014-04-14
Days to decision
242 days
Decision code
APPR
Product code
MAQ
Advisory committee
Microbiology
Expedited review
No
Location
Germantown, MD
Statement
APPROVAL FOR A MANUFACTURING SITE LOCATED AT QIAGEN INCORPORATED IN GERMANTOWN, MARYLAND.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.